Kathrin R. Sidell, Ph.D.
Affiliations: | Vanderbilt University, Nashville, TN |
Google:
"Kathrin Sidell"Mean distance: 19.27 (cluster 28)
Parents
Sign in to add mentor| Thomas J. Montine | grad student | 2001 | Vanderbilt | |
| (Metabolism of endogenous neurotoxins in neurodegenerative disease.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Sidell KR, Montine KS, Picklo MJ, et al. (2003) Mercapturate metabolism of 4-hydroxy-2-nonenal in rat and human cerebrum. Journal of Neuropathology and Experimental Neurology. 62: 146-53 |
| Montine KS, Sidell KR, Zhang J, et al. (2002) Dopamine thioethers: formation in brain and neurotoxicity. Neurotoxicity Research. 4: 663-669 |
| Sidell KR, Amamath V, Montine TJ. (2001) Dopamine thioethers in neurodegeneration. Current Topics in Medicinal Chemistry. 1: 519-27 |
| Sidell KR, Olson SJ, Ou JJ, et al. (2001) Cysteine and mercapturate conjugates of oxidized dopamine are in human striatum but only the cysteine conjugate impedes dopamine trafficking in vitro and in vivo. Journal of Neurochemistry. 79: 510-21 |
| Montine TJ, Amarnath V, Picklo MJ, et al. (2000) Dopamine mercapturate can augment dopaminergic neurodegeneration. Drug Metabolism Reviews. 32: 363-76 |
| Bassett CN, Neely MD, Sidell KR, et al. (1999) Cerebrospinal fluid lipoproteins are more vulnerable to oxidation in Alzheimer's disease and are neurotoxic when oxidized ex vivo. Lipids. 34: 1273-80 |
| Valyi-Nagy T, Sidell KR, Marnett LJ, et al. (1999) Divergence of brain prostaglandin H synthase activity and oxidative damage in mice with encephalitis. Journal of Neuropathology and Experimental Neurology. 58: 1269-75 |
| Montine TJ, Sidell KR, Crews BC, et al. (1999) Elevated CSF prostaglandin E2 levels in patients with probable AD. Neurology. 53: 1495-8 |
| Neely MD, Sidell KR, Graham DG, et al. (1999) The lipid peroxidation product 4-hydroxynonenal inhibits neurite outgrowth, disrupts neuronal microtubules, and modifies cellular tubulin. Journal of Neurochemistry. 72: 2323-33 |
| Montine KS, Reich E, Neely MD, et al. (1998) Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotype. Journal of Neuropathology and Experimental Neurology. 57: 415-25 |